- ISIN
- US03073E1055
- CUSIP
- 03071P102
- Sector
- Healthcare
- Industry
- Medical Distribution
- IPO Date
- Apr 4, 1995
Highlights
- Market Cap
- $53.00B
- Enterprise Value
- $63.42B
- EPS (TTM)
- $13.07
- PE Ratio
- 20.75
- PEG Ratio
- 9.86
- Total Revenue (TTM)
- $328.68B
- Gross Profit (TTM)
- $11.66B
- EBITDA (TTM)
- $3.64B
- Year Range
- $244.82 - $377.54
- Target Price
- $409.14
- ROA (TTM)
- 3.12%
- ROE (TTM)
- 75.01%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
COR Performance Chart
Cencora Inc. (COR) is down 19.4% since the beginning of the year. At $271 per share, COR is trading 28.1% below its 52-week high of $378. Investors who bought $1,000 worth of COR shares 5 years ago would now be looking at an investment worth $2,548.
Loading charts...
Returns By Period
Cencora Inc. (COR) has returned -19.36% so far this year and -6.92% over the past 12 months. Looking at the last ten years, COR has achieved an annualized return of 17.04%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.
Cencora Inc.
- 1D
- -0.20%
- 1M
- -1.32%
- YTD
- -19.36%
- 6M
- -19.90%
- 1Y
- -6.92%
- 3Y*
- 14.04%
- 5Y*
- 20.57%
- 10Y*
- 17.04%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
COR Monthly Returns History
Based on dividend-adjusted daily data since Apr 4, 1995, COR's average daily return is +0.08%, while the average monthly return is +1.70%. At this rate, an investment would double in approximately 3.4 years.
Historically, 61% of months were positive and 39% were negative. The best month was Sep 2000 with a return of +33.8%, while the worst month was Aug 1998 at -38.2%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.
On a daily basis, COR closed higher 52% of trading days. The best single day was Mar 16, 2000 with a return of +19.1%, while the worst single day was Oct 22, 1999 at -26.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.36% | 3.77% | -15.59% | -1.95% | -12.35% | 0.71% | -19.36% | ||||||
| 2025 | 13.14% | -0.04% | 9.68% | 5.24% | -0.30% | 2.96% | -4.59% | 2.12% | 7.17% | 8.09% | 9.39% | -8.45% | 51.48% |
| 2024 | 13.29% | 1.47% | 3.14% | -1.62% | -5.00% | -0.56% | 5.58% | 0.93% | -6.05% | 1.33% | 10.54% | -10.68% | 10.37% |
| 2023 | 1.96% | -7.65% | 2.92% | 4.21% | 2.27% | 13.09% | -2.87% | -5.60% | 2.27% | 2.88% | 10.13% | 0.99% | 25.33% |
| 2022 | 2.49% | 4.99% | 8.55% | -2.21% | 2.62% | -8.60% | 3.15% | 0.74% | -7.66% | 16.18% | 8.90% | -2.92% | 26.26% |
| 2021 | 6.59% | -2.46% | 17.86% | 2.31% | -4.67% | 0.90% | 6.71% | 0.40% | -1.22% | 2.15% | -4.79% | 16.08% | 44.09% |
Benchmark Metrics
Cencora Inc. has an annualized alpha of 16.07%, beta of 0.59, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since April 04, 1995.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (72.59%) than losses (23.70%) - typical of diversified or defensive assets.
- Beta of 0.59 may look defensive, but with R2 of 0.12 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 16.07%
- Beta
- 0.59
- R²
- 0.12
- Upside Capture
- 72.59%
- Downside Capture
- 23.70%
Return for Risk
Risk / Return Rank
COR ranks 31 for risk / return — below 31% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Cencora Inc. (COR) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| COR | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.26 | ||
| Sortino ratioReturn per unit of downside risk | -2.85 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.37 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | -0.21 | 2.78 | -3.00 |
| Martin ratioReturn relative to average drawdown | -0.57 | 12.44 | -13.01 |
Dividends
Dividend History
Cencora Inc. provided a 0.87% dividend yield over the last twelve months, with an annual payout of $2.35 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.35 | $2.25 | $2.08 | $1.97 | $1.87 | $6.82 | $6.59 | $6.36 | $1.54 | $1.48 | $1.39 | $1.21 |
Dividend yield | 0.87% | 0.67% | 0.93% | 0.96% | 1.13% | 5.13% | 6.74% | 7.48% | 2.07% | 1.61% | 1.77% | 1.17% |
Monthly Dividends
The table displays the monthly dividend distributions for Cencora Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $1.20 | ||||||
| 2025 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.60 | $0.00 | $2.25 |
| 2024 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.55 | $0.00 | $2.08 |
| 2023 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.51 | $0.00 | $1.97 |
| 2022 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.49 | $0.00 | $1.87 |
| 2021 | $0.00 | $0.44 | $1.23 | $0.00 | $0.44 | $1.27 | $0.00 | $0.44 | $1.27 | $0.00 | $0.46 | $1.27 | $6.82 |
Dividend Yield & Payout
Dividend Yield
Cencora Inc. has a dividend yield of 0.87%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Cencora Inc. has a payout ratio of 18.01%, which is below the market average. This means Cencora Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cencora Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cencora Inc. was 71.01%, occurring on Dec 3, 1999. Recovery took 203 trading sessions.
The current Cencora Inc. drawdown is 27.32%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1999 bear market1999 | -71.01%Dec 1999 | 10mo 15d | 9mo 24d | 1y 8moJan 1999 - Sep 2000 |
Financial crisis2007–2009 | -49.12%Nov 2008 | 1y 7mo | 1y 1mo | 2y 8moApr 2007 - Jan 2010 |
2003 bear market2003 | -43.09%Mar 2003 | 8mo 27d | 2y 9mo | 3y 6moJun 2002 - Dec 2005 |
1998 bear market1998 | -40.79%Sep 1998 | 1mo 7d | 4mo 11d | 5mo 18dJul 1998 - Jan 1999 |
2016 bear market2016 | -38.95%Nov 2016 | 1y 6mo | 3y 6mo | 5y 1moApr 2015 - Jun 2020 |
Drawdown Indicators
| COR | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.01% | -56.78% | -14.23% |
Max Drawdown (1Y)Largest decline over 1 year | -32.44% | -9.10% | -23.34% |
Max Drawdown (3Y)Largest decline over 3 years | -32.44% | -18.90% | -13.54% |
Max Drawdown (5Y)Largest decline over 5 years | -32.44% | -25.43% | -7.01% |
Max Drawdown (10Y)Largest decline over 10 years | -32.44% | -33.92% | +1.48% |
Current DrawdownCurrent decline from peak | -27.32% | -1.80% | -25.52% |
Average DrawdownAverage peak-to-trough decline | -13.63% | -10.71% | -2.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.23% | 2.03% | +10.20% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cencora Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Cencora Inc. is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for COR, comparing it with other companies in the Medical Distribution industry. Currently, COR has a P/E ratio of 20.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for COR compared to other companies in the Medical Distribution industry. COR currently has a PEG ratio of 9.9. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for COR relative to other companies in the Medical Distribution industry. Currently, COR has a P/S ratio of 0.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for COR in comparison with other companies in the Medical Distribution industry. Currently, COR has a P/B value of 15.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with COR
Add Cencora Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with COR